uPAR peptide antagonist alters regulation of MAP kinases and Bcl-2 family members in favor of apoptosis in MDA-MB-231 cell line.

Autor: Tarighi P; Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, I.R. Iran., Montazeri H; Department of Molecular Biology, Pasteur Institute of Iran, Tehran, I.R. Iran., Khorramizadeh MR; Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, I.R. Iran ; Biosensor Research Center, Endocrinology and Metabolism Molecular -Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, I.R. Iran., Sobhani AM; Department of Bioinformatics, Institute of Biochemistry and Biophysics, Tehran University, Tehran, I.R. Iran., Ostad SN; Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, I.R. Iran., Ghahremani MH; Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, I.R. Iran ; Department of Molecular Medicine, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, I.R. Iran.

Publikováno v: Research in pharmaceutical sciences [Res Pharm Sci] 2015 May-Jun; Vol. 10 (3), pp. 200-5.

A theory of mode of action of azolylalkylquinolines as DNA binding agents using automated flexible ligand docking.

Autor: Sobhani AM; Computational Chemistry Lab., Razi Institute for Drug Research, Iran University of Medical Sciences, Iran. armin@iums.ac.ir, Amini SR, Tyndall JD, Azizi E, Daneshtalab M, Khalaj A

Publikováno v: Journal of molecular graphics & modelling [J Mol Graph Model] 2006 Dec; Vol. 25 (4), pp. 459-69. Date of Electronic Publication: 2006 Apr 18.